Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Private placement?!

<< Previous

Bullboard Posts

Next >>

Comment by SleepyHowardon Mar 08, 2024 9:08am

101 Views

Post# 35922375

RE:RE:RE:Private placement?!

So true.
Feel sad for geraldine.
Would like to see the company with a professionell fulltime Management with experience.
Hope we will see a buyout soon before we loose all our money.
What about another q&a.
They told us that they will do that again.
No trust left

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario